Home

menu選單

按鈕:回到上頁return back
按鈕:01_B肝發現者hbv discoverer
按鈕:02女力當自強female scientist
按鈕:03_基礎醫學basic medicine
按鈕:04_臨床醫學clinical medicine
按鈕:05公衛推動
In 1963, Prof. Blumberg discovered the hepatitis B virus and in 1965, published his discovery. In 1966, he proposed the relationship between the ‘Australian antigen’ and acute viral hepatitis might be transmitted through transfusion. Blumberg and his team proposed to use hemophiliac patients to create a vaccine, and researchers at Merck & Co believed that this proposal could be instrumental in finding a vaccine. After getting the green light from his company, Blumberg began research on the hepatitis B vaccine in 1971. After countless researches and tests, a vaccine was eventually successfully produced from a surface antigen for hepatitis B. The vaccine provided more than 90% immunity for hepatitis B, and a plasma-derived hepatitis B vaccine was later approved in 1981.
Awards
1976年諾貝爾生理學或醫學獎
In 1981, Hilleman and his team treated blood serum with pepsin, urea, and formaldehyde to obtain a safe vaccine before further improvements to the vaccine were made in 1986. As of 2003, over 150 countries and regions were using the vaccine. Hilleman believed that the hepatitis B vaccine was his company’s (Merck & Co) greatest achievement. Due to the possible complication of liver cancer from hepatitis B, Hilleman’s vaccine can be said to be the world’s first cancer vaccine. In Taiwan, the usage of said vaccine has lowered the prevalence rate of hepatitis among infants by 99%.
Dr. R. Palmer Beasley was a physician, epidemiologist, and public health educator from the U.S. In 1972, Beasley visited Taiwan for the second time and conducted hepatitis B research. In 1975, vertical transmission between mother and infant was proven. While in 1981, Beasley showed that there existed a causal relationship between hepatitis and liver cancer. With the team consisting of Dr. Hwang Lu-Yu, Pediatrics, National Taiwan University Hospital; Prof. Lin Jia-Chin of National Taiwan University College of Public Health; postgraduate students Chen Chien-Jen, Twu Shiing-Jer; and Dr. Chang Mei-Hwei, Pediatrics, National Taiwan University Hospital; Beasley assisted in the pediatric screening for hepatitis and proved that the hepatitis B vaccine is able to effectively disrupt vertical transmission. A vaccine program was launched in 1984, and the country saw a significant decrease in newborn children carriers.
Further Reading
總統接見美國德州大學公共衛生學院院長畢思理夫婦
https://www.president.gov.tw/NEWS/2877
B肝發現者hbv discoverer
女力當自強female scientist
基礎科學basic medicine
臨床醫學clinical medicine
公衛推動文官public health
返回上頁return back
MOST科技部 logo
  • Home
  • History
  • Heros
  • Video
  • Classroom
  • Forums
  • PaGamO
  • News
web counter
  • tel:02-2352-6800 #885
  • E-mail:jimmy@mail.caita.org.tw
  • 中文
  • English
MOST科技部 logo
最新消息
News
B肝大事記
History
抗肝炎英雄
Heros
肝炎聖戰
Video
肝病科普小教室
Classroom
B肝40線上論壇
Forums
B肝小學堂
Games
MOST科技部 logo
News
News
History
History
Heros
Heros
Video
Video
Classroom
Classroom
Forums
Forums
Games
Games

Contact Us

  • tel: 02-2325-6800#885
  • E-mail:jimmy@mail.caita.org.tw

Video List

疫苗怎麼保護你

3:34

終結臺灣國病-B肝疫苗

7:08

B型肝炎防治

4:39

B型肝炎病毒發現史

4:46

下一個40年,臺灣醫學繼續守護你

1:30

Medicine Of Taiwan, Our liver protector

1:30

Forums Register